• Introduction
• Scope and Methodology
• Size and Growth of the Market
• Issues an Trends Affecting Market
• Leading Competitors

CHAPTER TWO: INTRODUCTION

• Introduction to Multiple Sclerosis
• Progression of Multiple Sclerosis
• Relapsing-remitting MS
• Primary-progressive MS
• Secondary-progressive MS
• Progressive-relapsing MS
• Benign MS
• Pathogenesis of MS
• Inflammatory Response and MS
• Triggers
• Risk Factors
• Physical Complications of MS
• Diagnosing MS
• Demographics and Statistics

CHAPTER THREE: TREATMENTS FOR MULTIPLE SCLEROSIS

• Description of Products
• Copaxone
• Avonex
• Rebif
• Betaferon/Betaseron
• Tysabri
• Novantrone
• Research and Development
• Late Stage Development
• Early to Mid Stage Development
• Phase II Development
• Phase I Development
• Preclinical Development and Research
• Experimental Drugs and Treatments
• Discontinued Development
• Market and Competitive Analysis
• World Market Analysis
• World Competitive Analysis
• Markets by World Region
• U.S. Market
• Europe Market
• Japan Market

CHAPTER FOUR: ISSUES AND TRENDS AFFECTING THE MS MARKET

• Introduction
• Medicare and Health Insurance Issues
• NIH MS Funding Reduction
• Stem Cell Controversy and MS
• Access to Life-Saving Medicine Act and MS
• Par-3 Discovery
• Cyclophilin D Regulation
• Women and MS
• Pregnancy and MS
• Alternative Therapies in MS Treatment
• MS and Diabetes

CHAPTER FIVE: COMPANY PROFILES

• Bayer Schering Pharma AG
• Biogen IDEC
• Novartis AG
• Sanofi-Aventis
• Merck Serono S.A.
• Teva Pharmaceutical Industries Ltd

APPENDIX: COMPANY NAMES AND ADDRESSES

• Table 1-1: Multiple Sclerosis Cases in Selected Countries.
• Table 1-2: The Worldwide Multiple Sclerosis Market 2004-2011
• Figure 1-1: The Worldwide Multiple Sclerosis Market 2004-2011

• Table 2-1: Estimated World Prevalence of Multiple Sclerosis by Selected Countries
• Figure 2-1: Estimated World Prevalence of Multiple Sclerosis by Selected Countries
• Table 2-2: World Population by Selected Geographical Region, 2006-2050
• Figure 2-2: World Population by Selected Geographical Region, 2006-2050
• Table 2-2: World Population by Selected Countries, 2006
• Figure 2-3: World Population by Selected Countries, 2006
• Table 2-3: Estimated World Population by Age, sex and Geographical Region, 2006
• Figure 2-4: Estimated World Population by Age and Geographical Region, 2006
• Figure 2-5: Estimated World Population by Sex and Geographical Region, 2006

• Table 3-1: Currently Available Multiple Sclerosis
• Treatments (Brand Name, Generic Name, Marketer and Approval Dates)
• Table 3-2: Estimated World Sales for Leading Products, 2004-2006
• Figure 3-1: Estimated World Sales for Leading Products, 2006
• Figure 3-2: Estimated World Sales for Leading Products 2004-2006
• Figure 3-3: Estimated World Sales for Leading Products, 2006
• Table 3-3: Multiple Sclerosis Products in Late Stage Development
• Table 3-4: Multiple Sclerosis Products in Early to Mid-Stage Development
• Table 3-5: The Worldwide Multiple Sclerosis Market 2004-2011
• Figure 3-4: The Worldwide Multiple Sclerosis Market 2004-2011
• Table 3-6: The Worldwide Multiple Sclerosis Market Estimated Revenues and Market Share of Leading Suppliers 2006
• Figure 3-5: The Worldwide Multiple Sclerosis Market Estimated Market Share by Leading Suppliers 2001
• Table 3-7: The Worldwide Multiple Sclerosis Market Projected Revenues and Market Share of Leading Suppliers 2011
• Figure 3-6: The Worldwide Multiple Sclerosis Market Projected Market Share by Leading Suppliers 2011
• Table 3-8: The Worldwide Multiple Sclerosis Market Estimated Products Sales by Geographic Region, 2004-2006
• Figure 3-7: The Worldwide Multiple Sclerosis Market Estimated Products Sales by Geographic Region, 2004-2006
• Figure 3-8: The Worldwide Multiple Sclerosis Market Estimated Products Sales by Geographic Region, 2004
• Figure 3-9: The Worldwide Multiple Sclerosis Market Estimated Products Sales by Geographic Region, 2005
• Figure 3-10: The Worldwide Multiple Sclerosis Market Estimated Products Sales by Geographic Region, 2006
• Table 3-9: The U.S. Multiple Sclerosis Market Estimated Revenues and Market Share of Leading Suppliers 2006
• Figure 3-13: The U.S. Multiple Sclerosis Market Projected Market Share by Leading Suppliers 2006
• Table 3-10: The European Multiple Sclerosis Market Estimated Revenues and Market Share of Leading Suppliers 2006
• Figure 3-14: The European Multiple Sclerosis Market Projected Market Share by Leading Suppliers 2006
• Table 3-11: The Japanese Multiple Sclerosis Market Estimated Revenues and Market Share of Leading Suppliers 2006
• Figure 3-15: The Japanese Multiple Sclerosis Market Projected Market Share by Leading Suppliers 2006

• Table 4-1: NIH Funding By Year